Massachusetts Financial Services
TBIO

Massachusetts Financial Services’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Massachusetts Financial Services’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-70,606
Closed -$1.94M – 959
2021
Q2 		$1.94M Buy
70,606
+605
+0.9% +$11.9K ﹤0.01% 784
2021
Q1 		$1.15M Buy
70,001
+31,738
+83% +$723K ﹤0.01% 825
2020
Q4 		$705K Sell
38,263
-384
-1% -$6.87K ﹤0.01% 821
2020
Q3 		$526K Buy
+38,647
New +$596K ﹤0.01% 824

Massachusetts Financial Services's TBIO Position: Q3 2021 in Review

Massachusetts Financial Services sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 70,606 shares — an estimated $1.94M sold.

Massachusetts Financial Services first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $1.94M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Massachusetts Financial Services reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 70,606 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.94M.
  • Massachusetts Financial Services first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Massachusetts Financial Services's Translate Bio, Inc. Common Stock position peaked at $1.94M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Massachusetts Financial Services's 13F filing for Q3 2021, filed 10 Nov 2021.